Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery (Catastim 2)
Primary Purpose
Neuromuscular Electrical Stimulation, Intensive Care Unit Acquired Weakness, Muscle Wasting
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Compex 3 Professional (CefarCompex Medical AB) stimulator
sham-stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Neuromuscular Electrical Stimulation
Eligibility Criteria
Inclusion Criteria:
- patients before/after cardiothoracic surgery
- ICU stay > 48 hours
Exclusion Criteria:
- body mass index > 40 kg/m2
- severe leg swelling
- implanted ventricular assist device (RVAD, LVAD, BiVAD)
- implanted intra-aortic balloon pump (IABP)
- neuromuscular diseases
- skin lesions in stimulation area
- leg excluded if implant (hip or knee replacement) in stimulation area
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
NMES group
Control group
Arm Description
Anterior muscles of both thighs were electrically stimulated twice a day (2×30 minutes of NMES with a break of at least 30 minutes between both sessions) 7 days a week during the entire ICU stay but no longer than 14 days, starting on postoperative day 1. Highest tolerable intensity was applied.
In the control group, the electrodes were applied, connected to the stimulator, but no electricity was delivered.
Outcomes
Primary Outcome Measures
Muscle layer thickness (MLT)
Muscle layer thickness of the anterior muscles of the thigh using two-dimensional B-mode ultrasound
Muscle strength
Muscle strength using Medical Research Council (MRC) score and hand dynamometry
Secondary Outcome Measures
JAGS score
JAGS score
Timed Up and Go test
Timed Get Up and Go test
FIM score
Functional Independance Measure (FIM) score
SF-12 score
12-item Short Form Health Survey (SF-12)
Full Information
NCT ID
NCT02391103
First Posted
March 7, 2015
Last Updated
July 6, 2015
Sponsor
Medical University of Vienna
1. Study Identification
Unique Protocol Identification Number
NCT02391103
Brief Title
Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery
Acronym
Catastim 2
Official Title
Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery. An Ultrasound-Based Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2015
Overall Recruitment Status
Completed
Study Start Date
May 2011 (undefined)
Primary Completion Date
July 2012 (Actual)
Study Completion Date
March 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Vienna
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purposes of this study are 1) to determine whether neuromuscular electrical stimulation (NMES) is effective in preventing loss of muscle mass and strength and 2) to observe the time variation of MLT and strength from preoperative day to hospital discharge.
Detailed Description
In the amendment of June 2011, a twofold study setting was defined in order to recruit patients not only before, but also after cardiothoracic surgery. In sample A, patients were recruited before surgery. In sample B, patients were recruited after surgery. On postoperative day 1, randomization was performed for sample A and B separately. To ensure balance of the NMES and control groups with respect to disease severity, randomization was stratified by the SAPS II score on the first postoperative day. In the intervention group, the anterior muscles of both thighs were electrically stimulated from the first postoperative day until ICU discharge for a maximum of 14 days. In the control group, the electrodes were applied, but no electricity was delivered.The primary outcomes muscle layer thickness (MLT) and muscle strength were assessed from the first postoperative day to ICU discharge and at hospital discharge. All patients in sample A had an additional assessment of MLT and strength before surgery.
All data are analyzed according to the intention-to-treat principle with no imputation for any missing data. Linear mixed models are used to account for the repeated measurements per patient and to determine any fixed effects on MLT and MRC score.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuromuscular Electrical Stimulation, Intensive Care Unit Acquired Weakness, Muscle Wasting, Muscle Loss
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
54 (Actual)
8. Arms, Groups, and Interventions
Arm Title
NMES group
Arm Type
Experimental
Arm Description
Anterior muscles of both thighs were electrically stimulated twice a day (2×30 minutes of NMES with a break of at least 30 minutes between both sessions) 7 days a week during the entire ICU stay but no longer than 14 days, starting on postoperative day 1. Highest tolerable intensity was applied.
Arm Title
Control group
Arm Type
Sham Comparator
Arm Description
In the control group, the electrodes were applied, connected to the stimulator, but no electricity was delivered.
Intervention Type
Device
Intervention Name(s)
Compex 3 Professional (CefarCompex Medical AB) stimulator
Intervention Description
NMES
Intervention Type
Device
Intervention Name(s)
sham-stimulation
Intervention Description
no electricity applied
Primary Outcome Measure Information:
Title
Muscle layer thickness (MLT)
Description
Muscle layer thickness of the anterior muscles of the thigh using two-dimensional B-mode ultrasound
Time Frame
on preoperative day, from postoperative day 1 onwards every other ICU day for the duration of the ICU stay (expected average of ICU stay: 7 days) and at day of hospital discharge (expected average of hospital stay: 20 days)
Title
Muscle strength
Description
Muscle strength using Medical Research Council (MRC) score and hand dynamometry
Time Frame
on preoperative day, from postoperative day 1 onwards every day for the duration of the ICU stay (expected average of ICU stay: 7 days), at day of hospital discharge (expected average of hospital stay: 20 days)
Secondary Outcome Measure Information:
Title
JAGS score
Description
JAGS score
Time Frame
on preoperative day, on day of ICU discharge (expected average of ICU stay: 7 days), on day of hospital discharge (expected average of hospital stay: 20 days)
Title
Timed Up and Go test
Description
Timed Get Up and Go test
Time Frame
on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)
Title
FIM score
Description
Functional Independance Measure (FIM) score
Time Frame
on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)
Title
SF-12 score
Description
12-item Short Form Health Survey (SF-12)
Time Frame
on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients before/after cardiothoracic surgery
ICU stay > 48 hours
Exclusion Criteria:
body mass index > 40 kg/m2
severe leg swelling
implanted ventricular assist device (RVAD, LVAD, BiVAD)
implanted intra-aortic balloon pump (IABP)
neuromuscular diseases
skin lesions in stimulation area
leg excluded if implant (hip or knee replacement) in stimulation area
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael Hiesmayr, MD, Prof.
Organizational Affiliation
Medical University of Vienna
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Arabella Fischer, MD
Organizational Affiliation
Medical University of Vienna
Official's Role
Principal Investigator
12. IPD Sharing Statement
Citations:
PubMed Identifier
19814793
Citation
Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E, Politis P, Koroneos A, Chatzimichail A, Routsi C, Roussos C, Nanas S. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Crit Care. 2009;13(5):R161. doi: 10.1186/cc8123. Epub 2009 Oct 8.
Results Reference
background
PubMed Identifier
23561945
Citation
Hirose T, Shiozaki T, Shimizu K, Mouri T, Noguchi K, Ohnishi M, Shimazu T. The effect of electrical muscle stimulation on the prevention of disuse muscle atrophy in patients with consciousness disturbance in the intensive care unit. J Crit Care. 2013 Aug;28(4):536.e1-7. doi: 10.1016/j.jcrc.2013.02.010. Epub 2013 Apr 3.
Results Reference
background
PubMed Identifier
21715139
Citation
Rodriguez PO, Setten M, Maskin LP, Bonelli I, Vidomlansky SR, Attie S, Frosiani SL, Kozima S, Valentini R. Muscle weakness in septic patients requiring mechanical ventilation: protective effect of transcutaneous neuromuscular electrical stimulation. J Crit Care. 2012 Jun;27(3):319.e1-8. doi: 10.1016/j.jcrc.2011.04.010. Epub 2011 Jun 28.
Results Reference
background
PubMed Identifier
25307979
Citation
Kho ME, Truong AD, Zanni JM, Ciesla ND, Brower RG, Palmer JB, Needham DM. Neuromuscular electrical stimulation in mechanically ventilated patients: a randomized, sham-controlled pilot trial with blinded outcome assessment. J Crit Care. 2015 Feb;30(1):32-9. doi: 10.1016/j.jcrc.2014.09.014. Epub 2014 Sep 22.
Results Reference
background
PubMed Identifier
21349913
Citation
Abdellaoui A, Prefaut C, Gouzi F, Couillard A, Coisy-Quivy M, Hugon G, Molinari N, Lafontaine T, Jonquet O, Laoudj-Chenivesse D, Hayot M. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study. Eur Respir J. 2011 Oct;38(4):781-8. doi: 10.1183/09031936.00167110. Epub 2011 Feb 24.
Results Reference
background
PubMed Identifier
20426834
Citation
Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, Markaki V, Zervakis D, Nanas S. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010;14(2):R74. doi: 10.1186/cc8987. Epub 2010 Apr 28.
Results Reference
background
PubMed Identifier
12853536
Citation
Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest. 2003 Jul;124(1):292-6. doi: 10.1378/chest.124.1.292.
Results Reference
background
PubMed Identifier
25882765
Citation
Puthucheary ZA, Phadke R, Rawal J, McPhail MJ, Sidhu PS, Rowlerson A, Moxham J, Harridge S, Hart N, Montgomery HE. Qualitative Ultrasound in Acute Critical Illness Muscle Wasting. Crit Care Med. 2015 Aug;43(8):1603-11. doi: 10.1097/CCM.0000000000001016.
Results Reference
background
PubMed Identifier
24108501
Citation
Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, Hopkinson NS, Phadke R, Dew T, Sidhu PS, Velloso C, Seymour J, Agley CC, Selby A, Limb M, Edwards LM, Smith K, Rowlerson A, Rennie MJ, Moxham J, Harridge SD, Hart N, Montgomery HE. Acute skeletal muscle wasting in critical illness. JAMA. 2013 Oct 16;310(15):1591-600. doi: 10.1001/jama.2013.278481. Erratum In: JAMA. 2014 Feb 12;311(6):625. Padhke, Rahul [corrected to Phadke, Rahul].
Results Reference
background
PubMed Identifier
26825278
Citation
Fischer A, Spiegl M, Altmann K, Winkler A, Salamon A, Themessl-Huber M, Mouhieddine M, Strasser EM, Schiferer A, Paternostro-Sluga T, Hiesmayr M. Muscle mass, strength and functional outcomes in critically ill patients after cardiothoracic surgery: does neuromuscular electrical stimulation help? The Catastim 2 randomized controlled trial. Crit Care. 2016 Jan 29;20:30. doi: 10.1186/s13054-016-1199-3.
Results Reference
derived
Learn more about this trial
Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery
We'll reach out to this number within 24 hrs